The researchers attempted to distribute physician recruitment in a representative manner, including physicians from major urban hubs across a variety of regions in China; however, due to the focus on urban populations, the survey results may or may not have been reflective of HR+/HER2(−) breast cancer treatment patterns across the larger Chinese population. Here, ERBB2 is linked to breast cancer.